Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

1 Division of Pulmonary and Critical Care, Department of Internal Medicine, Tannourine Governmental Hospital, Batroun, Lebanon. 2 Division of Pulmonary and Critical Care, Department of Internal ...

The current pathophysiology of COPD encompasses three main characteristics: emphysema, chronic bronchitis and small airway disease. Macrophages and neutrophils are implicated in this process ...

IPF affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition develops when lung tissue becomes ...

First-in-class, steroid-free compound reduced inflammatory and fibrotic biomarkers in human lung tissue furthering support as a new advancement in the treatment of deadly lung diseasesCUMBERLAND, Md., ...

Computational physiology is an emerging field that leverages ... which can be used to classify conditions like Chronic Obstructive Pulmonary Disease (COPD). The findings suggest that in-ear ...

Workshop on Yogic Management of Respiratory Disorders held at MDNIY in New Delhi: Our Bureau, Chennai Saturday, January 25, 2025, 08:00 Hrs [IST] A special workshop on ‘Yogic Ma ...

Commissioned by the American Department for Health and Social Care, the research found that men lose an average of 17 minutes per cigarette, while women lose a staggering 22 minutes. These figures ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

While advancements like Trikafta have significantly improved pulmonary outcomes ... offering new insights into the disease's ...